Page last updated: 2024-10-30

leflunomide and Hyperglycemia, Postprandial

leflunomide has been researched along with Hyperglycemia, Postprandial in 2 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Hyperglycemia, Postprandial: Abnormally high BLOOD GLUCOSE level after a meal.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, J1
Sun, J1
Doscas, ME1
Ye, J1
Williamson, AJ1
Li, Y2
Prinz, RA1
Xu, X1
Stosić-Grujicić, S1
Dimitrijević, M1
Bartlett, RR1

Other Studies

2 other studies available for leflunomide and Hyperglycemia, Postprandial

ArticleYear
Control of hyperglycemia in male mice by leflunomide: mechanisms of action.
    The Journal of endocrinology, 2018, Volume: 237, Issue:1

    Topics: 3T3-L1 Cells; Aniline Compounds; Animals; Blood Glucose; Cells, Cultured; Crotonates; Glucose; Gluco

2018
A novel immunomodulating agent--leflunomide inhibits experimental autoimmune diabetes in mice.
    Transplantation proceedings, 1996, Volume: 28, Issue:6

    Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Hyperglycemia; I

1996